共 90 条
- [11] Barzegar O(2021)Registry of patients with multiple sclerosis an COVID-19 infection in Saudi Arabia Mult Scler Relat Disord 8 e1024-330
- [12] Mirmosayyeb M(2021)SARS-CoV-2 Infection in Multiple Sclerosis: Results of the Spanish Neurology Society Registry Neurol Neuroimmunol Neuroinflammation 45 102276-1213
- [13] Gajarzadeh D(2020)Characteristics of COVID-19 disease in multiple sclerosis patients Mult Scler Relat Disord 16 e0255316-8
- [14] Moher A(2020)SARS-CoV-2 infection among patients with multiple sclerosis: a cross-sectional study MedRxiv 418 117147-1162
- [15] Liberati J(2021)Incidence and clinical outcome of Coronavirus disease 2019 in a cohort of 11,560 Brazilian patients with multiple sclerosis Mult Scler 45 102392-undefined
- [16] Tetzlaff D(2021)COVID-19 severity and mortality in multiple sclerosis are not associated with immunotherapy: insights from a nation-wide Austrian registry PLoS ONE 55 11-undefined
- [17] O’Sullivan S(2020)COVID-19 in multiple sclerosis patients and risk factors for severe infection J Neurol Sci 26 1256-undefined
- [18] Wilk W(2020)COVID-19 in MS and NMOSD: a multicentric online national survey in Chile Mult Scler Relat Disord 77 1079-undefined
- [19] Michalowski A(2021)Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies—the Polish experience Neurol Neurochir Pol 7 e835-undefined
- [20] Scalfari V(2020)COVID-19 in multiple sclerosis: the Dutch experience Mult Scler 46 102472-undefined